Hiroyuki Hamakawa
Toon, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Corrigendum: The CUL3-SPOP-DAXX axis is a novel regulator of VEGFR2 expression in vascular endothelial cells.
Journal: Scientific reports
Published: December 23, 2017
Multicenter retrospective study of cetuximab plus platinum-based chemotherapy for recurrent or metastatic oral squamous cell carcinoma.
Journal: Cancer chemotherapy and pharmacology
Published: September 22, 2017
Palonosetron Prevents Highly Emetogenic Chemotherapy-induced Nausea and Vomiting in Oral Cancer Patients.
Journal: Anticancer research
Published: September 18, 2017
The CUL3-SPOP-DAXX axis is a novel regulator of VEGFR2 expression in vascular endothelial cells.
Journal: Scientific reports
Published: July 14, 2016
Suppression of invasion and metastasis in aggressive salivary cancer cells through targeted inhibition of ID1 gene expression.
Journal: Cancer letters
Published: February 10, 2016
Comprehensive assessment of the prognosis of pancreatic cancer: peripheral blood neutrophil-lymphocyte ratio and immunohistochemical analyses of the tumour site.
Journal: Scandinavian journal of gastroenterology
Published: December 19, 2015
Prognostic impact of preoperative serum interleukin-6 levels in patients with early-stage oral squamous cell carcinoma, defined by sentinel node biopsy.
Journal: Oncology letters
Published: September 09, 2015
Clinical implication of blood glucose monitoring in general dental offices: the Ehime Dental Diabetes Study.
Journal: BMJ open diabetes research & care
Published: August 21, 2015
A Clinical Investigation of Oral Sarcomas at Multi-institutions Over the Past 30 Years.
Journal: Anticancer research
Published: July 14, 2015
Last Updated: 09/26/2026